Infectious Diseases

September 4, 2024

Bacterial metabolism plays role in staph antibiotic tolerance

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

(iStock)
August 13, 2024

VUMC, DOD join forces for a hantavirus antibody “sprint”

VUMC’s antibody collaboration with the DOD goes back to 2018, when the medical center signed a five-year cooperative agreement with the U.S. Defense Advanced Research Projects Agency to develop protective treatments that can be rushed to health care providers within weeks after a viral outbreak.

Kelly Dooley, MD, PhD, MPH. (photo by Susan Urmy)
July 23, 2024

VUMC joins $31 million project to speed new TB therapies

Sweeping data integration and clinical trial simulations are needed to help decide which targets to prioritize in researching new tuberculosis treatment regimens.

July 12, 2024

Wesley Self named to leadership role in global clinical trials network

The Strategies and Treatments for Respiratory Infections and Viral Emergencies network includes more than 300 sites around the world and international experts in clinical trials, infectious diseases, critical care and pandemic preparedness.

Anthony Flores, MD, MPH, PhD
July 12, 2024

Anthony Flores named director of the Division of Pediatric Infectious Diseases

In his clinical and research work, Flores examines the mechanisms by which bacterial pathogens cause disease in humans.

Jennifer Gaddy, PhD
July 11, 2024

Jennifer Gaddy receives grants from March of Dimes, Burroughs Wellcome Fund

She studies infection of the female reproductive tract in the context of pregnancy.